nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—appendage—bone cancer	0.121	0.392	CbGeAlD
Pentosan Polysulfate—FGF1—periosteum—bone cancer	0.0525	0.17	CbGeAlD
Pentosan Polysulfate—FGF1—cartilage tissue—bone cancer	0.0368	0.119	CbGeAlD
Pentosan Polysulfate—FGF4—connective tissue—bone cancer	0.0346	0.112	CbGeAlD
Pentosan Polysulfate—FGF1—appendage—bone cancer	0.032	0.104	CbGeAlD
Pentosan Polysulfate—FGF1—connective tissue—bone cancer	0.00915	0.0296	CbGeAlD
Pentosan Polysulfate—FGF2—tendon—bone cancer	0.00845	0.0274	CbGeAlD
Pentosan Polysulfate—FGF2—spinal cord—bone cancer	0.00815	0.0264	CbGeAlD
Pentosan Polysulfate—FGF1—spinal cord—bone cancer	0.00606	0.0196	CbGeAlD
Pentosan Polysulfate—Optic neuritis—Cisplatin—bone cancer	0.00508	0.0226	CcSEcCtD
Pentosan Polysulfate—Prothrombin level increased—Epirubicin—bone cancer	0.00391	0.0174	CcSEcCtD
Pentosan Polysulfate—Infection—Carboplatin—bone cancer	0.00378	0.0168	CcSEcCtD
Pentosan Polysulfate—Raised liver function tests—Methotrexate—bone cancer	0.00372	0.0165	CcSEcCtD
Pentosan Polysulfate—Prothrombin level increased—Doxorubicin—bone cancer	0.00362	0.0161	CcSEcCtD
Pentosan Polysulfate—Appetite absent—Methotrexate—bone cancer	0.00345	0.0153	CcSEcCtD
Pentosan Polysulfate—Gingival bleeding—Epirubicin—bone cancer	0.00283	0.0126	CcSEcCtD
Pentosan Polysulfate—Lacrimation—Epirubicin—bone cancer	0.00273	0.0121	CcSEcCtD
Pentosan Polysulfate—Pelvic pain—Epirubicin—bone cancer	0.00264	0.0117	CcSEcCtD
Pentosan Polysulfate—Gingival bleeding—Doxorubicin—bone cancer	0.00262	0.0116	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Epirubicin—bone cancer	0.00261	0.0116	CcSEcCtD
Pentosan Polysulfate—Lacrimation—Doxorubicin—bone cancer	0.00253	0.0112	CcSEcCtD
Pentosan Polysulfate—Pelvic pain—Doxorubicin—bone cancer	0.00244	0.0109	CcSEcCtD
Pentosan Polysulfate—Optic neuritis—Doxorubicin—bone cancer	0.00241	0.0107	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Epirubicin—bone cancer	0.00225	0.01	CcSEcCtD
Pentosan Polysulfate—Dehydration—Cisplatin—bone cancer	0.00211	0.00939	CcSEcCtD
Pentosan Polysulfate—Nystagmus—Doxorubicin—bone cancer	0.00208	0.00925	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Epirubicin—bone cancer	0.00208	0.00925	CcSEcCtD
Pentosan Polysulfate—Amblyopia—Doxorubicin—bone cancer	0.00192	0.00856	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Cisplatin—bone cancer	0.00191	0.0085	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Cisplatin—bone cancer	0.00188	0.00837	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Epirubicin—bone cancer	0.00183	0.00813	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Epirubicin—bone cancer	0.00178	0.00791	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Epirubicin—bone cancer	0.00174	0.00775	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Methotrexate—bone cancer	0.00172	0.00763	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Cisplatin—bone cancer	0.0017	0.00758	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Cisplatin—bone cancer	0.0017	0.00756	CcSEcCtD
Pentosan Polysulfate—Amenorrhoea—Doxorubicin—bone cancer	0.00169	0.00752	CcSEcCtD
Pentosan Polysulfate—Rectal haemorrhage—Doxorubicin—bone cancer	0.00164	0.00732	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Methotrexate—bone cancer	0.00162	0.00721	CcSEcCtD
Pentosan Polysulfate—Lacrimation increased—Doxorubicin—bone cancer	0.00161	0.00717	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Epirubicin—bone cancer	0.00161	0.00714	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Methotrexate—bone cancer	0.00155	0.0069	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Methotrexate—bone cancer	0.00155	0.0069	CcSEcCtD
Pentosan Polysulfate—Colitis—Epirubicin—bone cancer	0.00154	0.00686	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Epirubicin—bone cancer	0.00152	0.00674	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Doxorubicin—bone cancer	0.00149	0.00661	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Epirubicin—bone cancer	0.00147	0.00653	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Cisplatin—bone cancer	0.00146	0.00651	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Epirubicin—bone cancer	0.00145	0.00646	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Epirubicin—bone cancer	0.00145	0.00646	CcSEcCtD
Pentosan Polysulfate—Colitis—Doxorubicin—bone cancer	0.00143	0.00635	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Methotrexate—bone cancer	0.00142	0.00631	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Doxorubicin—bone cancer	0.0014	0.00624	CcSEcCtD
Pentosan Polysulfate—Alopecia—Cisplatin—bone cancer	0.00139	0.00617	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Doxorubicin—bone cancer	0.00136	0.00604	CcSEcCtD
Pentosan Polysulfate—Flatulence—Cisplatin—bone cancer	0.00135	0.00599	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Doxorubicin—bone cancer	0.00134	0.00598	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Doxorubicin—bone cancer	0.00134	0.00598	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Epirubicin—bone cancer	0.00133	0.0059	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Cisplatin—bone cancer	0.00127	0.00564	CcSEcCtD
Pentosan Polysulfate—Anaemia—Cisplatin—bone cancer	0.00126	0.00562	CcSEcCtD
Pentosan Polysulfate—Malaise—Cisplatin—bone cancer	0.00123	0.00548	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—bone cancer	0.00123	0.00546	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Cisplatin—bone cancer	0.00122	0.00544	CcSEcCtD
Pentosan Polysulfate—Mood swings—Methotrexate—bone cancer	0.00118	0.00525	CcSEcCtD
Pentosan Polysulfate—Myalgia—Cisplatin—bone cancer	0.00116	0.00518	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Methotrexate—bone cancer	0.00115	0.00511	CcSEcCtD
Pentosan Polysulfate—Discomfort—Cisplatin—bone cancer	0.00115	0.00511	CcSEcCtD
Pentosan Polysulfate—Affect lability—Epirubicin—bone cancer	0.00115	0.0051	CcSEcCtD
Pentosan Polysulfate—Oedema—Cisplatin—bone cancer	0.00112	0.00496	CcSEcCtD
Pentosan Polysulfate—Infection—Cisplatin—bone cancer	0.00111	0.00493	CcSEcCtD
Pentosan Polysulfate—Mood swings—Epirubicin—bone cancer	0.0011	0.00491	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Cisplatin—bone cancer	0.00109	0.00486	CcSEcCtD
Pentosan Polysulfate—Dehydration—Epirubicin—bone cancer	0.00108	0.00482	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Cisplatin—bone cancer	0.00108	0.0048	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Epirubicin—bone cancer	0.00108	0.00479	CcSEcCtD
Pentosan Polysulfate—Anorexia—Cisplatin—bone cancer	0.00106	0.00473	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—bone cancer	0.00106	0.00472	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Methotrexate—bone cancer	0.00103	0.00459	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—bone cancer	0.00103	0.00459	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—bone cancer	0.00102	0.00454	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00102	0.00452	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—bone cancer	0.001	0.00446	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Cisplatin—bone cancer	0.001	0.00446	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—bone cancer	0.000995	0.00443	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Cisplatin—bone cancer	0.000994	0.00442	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Methotrexate—bone cancer	0.000982	0.00437	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—bone cancer	0.000981	0.00436	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Cisplatin—bone cancer	0.000969	0.00431	CcSEcCtD
Pentosan Polysulfate—Depression—Methotrexate—bone cancer	0.000957	0.00426	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—bone cancer	0.000954	0.00425	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—MDM2—bone cancer	0.000937	0.00201	CbGpPWpGaD
Pentosan Polysulfate—Stomatitis—Methotrexate—bone cancer	0.000935	0.00416	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—BRAF—bone cancer	0.000933	0.002	CbGpPWpGaD
Pentosan Polysulfate—Conjunctivitis—Methotrexate—bone cancer	0.000933	0.00415	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—bone cancer	0.00093	0.00414	CcSEcCtD
Pentosan Polysulfate—Sweating—Methotrexate—bone cancer	0.00092	0.00409	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—bone cancer	0.000919	0.00409	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Cisplatin—bone cancer	0.000919	0.00409	CcSEcCtD
Pentosan Polysulfate—FGF1—B Cell Activation—KIT—bone cancer	0.000918	0.00197	CbGpPWpGaD
Pentosan Polysulfate—Weight increased—Epirubicin—bone cancer	0.000916	0.00408	CcSEcCtD
Pentosan Polysulfate—Haematuria—Methotrexate—bone cancer	0.000915	0.00407	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by FGFR—BRAF—bone cancer	0.000913	0.00196	CbGpPWpGaD
Pentosan Polysulfate—Weight decreased—Epirubicin—bone cancer	0.000911	0.00405	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—bone cancer	0.000908	0.00404	CcSEcCtD
Pentosan Polysulfate—FGF4—Downstream signal transduction—EGFR—bone cancer	0.000908	0.00195	CbGpPWpGaD
Pentosan Polysulfate—Epistaxis—Methotrexate—bone cancer	0.000905	0.00403	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 interactions—KIT—bone cancer	0.000905	0.00194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—KIT—bone cancer	0.000905	0.00194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—KIT—bone cancer	0.000905	0.00194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000904	0.00194	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by FGFR—EGFR—bone cancer	0.000903	0.00194	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by ERBB2—EGFR—bone cancer	0.000899	0.00193	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—MDM2—bone cancer	0.000897	0.00192	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—KIT—bone cancer	0.000897	0.00192	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 signaling—EGFR—bone cancer	0.000894	0.00192	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—KIT—bone cancer	0.000889	0.00191	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—KIT—bone cancer	0.000885	0.0019	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—MDM2—bone cancer	0.000883	0.00189	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bone cancer	0.000881	0.00189	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.000879	0.00188	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—EGFR—bone cancer	0.000877	0.00188	CbGpPWpGaD
Pentosan Polysulfate—Jaundice—Epirubicin—bone cancer	0.000875	0.00389	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—bone cancer	0.000875	0.00389	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—bone cancer	0.000873	0.00388	CcSEcCtD
Pentosan Polysulfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—EGFR—bone cancer	0.000868	0.00186	CbGpPWpGaD
Pentosan Polysulfate—Sweating—Epirubicin—bone cancer	0.000861	0.00383	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—bone cancer	0.000861	0.00383	CcSEcCtD
Pentosan Polysulfate—FGF1—PI-3K cascade—EGFR—bone cancer	0.000857	0.00184	CbGpPWpGaD
Pentosan Polysulfate—Haematuria—Epirubicin—bone cancer	0.000856	0.00381	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Methotrexate—bone cancer	0.000855	0.0038	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—MDM2—bone cancer	0.000855	0.00183	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—BRAF—bone cancer	0.000851	0.00182	CbGpPWpGaD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—bone cancer	0.000851	0.00378	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—bone cancer	0.000848	0.00377	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—bone cancer	0.000847	0.00377	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signal transduction—MDM2—bone cancer	0.000843	0.00181	CbGpPWpGaD
Pentosan Polysulfate—Weight decreased—Doxorubicin—bone cancer	0.000843	0.00375	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—bone cancer	0.000842	0.00375	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling by FGFR in disease—EGFR—bone cancer	0.000841	0.0018	CbGpPWpGaD
Pentosan Polysulfate—FGF4—DAP12 interactions—EGFR—bone cancer	0.000841	0.0018	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.000841	0.0018	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—MDM2—bone cancer	0.000839	0.0018	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—MDM2—bone cancer	0.000839	0.0018	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—KIT—bone cancer	0.000837	0.0018	CbGpPWpGaD
Pentosan Polysulfate—FGF1—PI3K/AKT activation—EGFR—bone cancer	0.000837	0.00179	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—MDM2—bone cancer	0.000835	0.00179	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR—EGFR—bone cancer	0.000834	0.00179	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 signaling—MDM2—bone cancer	0.000831	0.00178	CbGpPWpGaD
Pentosan Polysulfate—FGF1—GAB1 signalosome—EGFR—bone cancer	0.00083	0.00178	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by EGFR in Cancer—EGFR—bone cancer	0.000826	0.00177	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.000826	0.00177	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by PDGF—EGFR—bone cancer	0.000823	0.00176	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Cisplatin—bone cancer	0.000822	0.00366	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—MDM2—bone cancer	0.000819	0.00176	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—MDM2—bone cancer	0.000818	0.00175	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—bone cancer	0.000811	0.00174	CbGpPWpGaD
Pentosan Polysulfate—Stomatitis—Doxorubicin—bone cancer	0.00081	0.0036	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—bone cancer	0.00081	0.0036	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—bone cancer	0.000808	0.0036	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—bone cancer	0.000808	0.00359	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—MDM2—bone cancer	0.000805	0.00173	CbGpPWpGaD
Pentosan Polysulfate—Tinnitus—Methotrexate—bone cancer	0.000803	0.00357	CcSEcCtD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.000801	0.00172	CbGpPWpGaD
Pentosan Polysulfate—Pharyngitis—Epirubicin—bone cancer	0.0008	0.00356	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—bone cancer	0.000796	0.00354	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—MMP9—bone cancer	0.000793	0.0017	CbGpPWpGaD
Pentosan Polysulfate—Haematuria—Doxorubicin—bone cancer	0.000792	0.00352	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—bone cancer	0.000784	0.00349	CcSEcCtD
Pentosan Polysulfate—FGF2—PI-3K cascade—EGFR—bone cancer	0.000782	0.00168	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—MDM2—bone cancer	0.000781	0.00168	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—MDM2—bone cancer	0.000781	0.00168	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—MDM2—bone cancer	0.000781	0.00168	CbGpPWpGaD
Pentosan Polysulfate—Sinusitis—Doxorubicin—bone cancer	0.000779	0.00347	CcSEcCtD
Pentosan Polysulfate—FGF4—B Cell Activation—EGFR—bone cancer	0.000779	0.00167	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR—MDM2—bone cancer	0.000775	0.00166	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—RGS1—bone cancer	0.000774	0.00166	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—GRM4—bone cancer	0.000774	0.00166	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—MDM2—bone cancer	0.000769	0.00165	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—MDM2—bone cancer	0.000768	0.00165	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—MDM2—bone cancer	0.000765	0.00164	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—MDM2—bone cancer	0.000764	0.00164	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Cisplatin—bone cancer	0.000763	0.0034	CcSEcCtD
Pentosan Polysulfate—FGF2—PI3K/AKT activation—EGFR—bone cancer	0.000763	0.00164	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—MDM2—bone cancer	0.000761	0.00163	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Methotrexate—bone cancer	0.000761	0.00339	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 signaling—MDM2—bone cancer	0.000758	0.00162	CbGpPWpGaD
Pentosan Polysulfate—FGF2—GAB1 signalosome—EGFR—bone cancer	0.000757	0.00162	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.000753	0.00162	CbGpPWpGaD
Pentosan Polysulfate—Tinnitus—Epirubicin—bone cancer	0.000752	0.00334	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—bone cancer	0.000748	0.00333	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—MDM2—bone cancer	0.000747	0.0016	CbGpPWpGaD
Pentosan Polysulfate—FGF4—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000745	0.0016	CbGpPWpGaD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—bone cancer	0.00074	0.00329	CcSEcCtD
Pentosan Polysulfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—bone cancer	0.00074	0.00159	CbGpPWpGaD
Pentosan Polysulfate—FGF4—MAPK Signaling Pathway—TP53—bone cancer	0.000737	0.00158	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000735	0.00158	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—MDM2—bone cancer	0.000723	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—MMP9—bone cancer	0.000723	0.00155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—MDM2—bone cancer	0.000713	0.00153	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—MDM2—bone cancer	0.000713	0.00153	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—MDM2—bone cancer	0.000713	0.00153	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Epirubicin—bone cancer	0.000712	0.00317	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—ENO2—bone cancer	0.000712	0.00153	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Cisplatin—bone cancer	0.000709	0.00315	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000709	0.00152	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—MDM2—bone cancer	0.000706	0.00151	CbGpPWpGaD
Pentosan Polysulfate—Rash—Cisplatin—bone cancer	0.000703	0.00313	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Cisplatin—bone cancer	0.000702	0.00313	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—MDM2—bone cancer	0.0007	0.0015	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—MDM2—bone cancer	0.000697	0.00149	CbGpPWpGaD
Pentosan Polysulfate—Ill-defined disorder—Methotrexate—bone cancer	0.000696	0.0031	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—bone cancer	0.000695	0.00309	CcSEcCtD
Pentosan Polysulfate—Anaemia—Methotrexate—bone cancer	0.000693	0.00308	CcSEcCtD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.000692	0.00148	CbGpPWpGaD
Pentosan Polysulfate—Flatulence—Epirubicin—bone cancer	0.000691	0.00308	CcSEcCtD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—JUN—bone cancer	0.000679	0.00146	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—ATF1—bone cancer	0.000677	0.00145	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Methotrexate—bone cancer	0.000676	0.00301	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—KIT—bone cancer	0.000676	0.00145	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Methotrexate—bone cancer	0.000671	0.00299	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—GRM1—bone cancer	0.000671	0.00144	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000671	0.00144	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Cisplatin—bone cancer	0.000662	0.00295	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—DHFR—bone cancer	0.000661	0.00142	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—MDM2—bone cancer	0.00066	0.00141	CbGpPWpGaD
Pentosan Polysulfate—Alopecia—Doxorubicin—bone cancer	0.000659	0.00293	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—bone cancer	0.000651	0.0029	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—bone cancer	0.000649	0.00289	CcSEcCtD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000646	0.00139	CbGpPWpGaD
Pentosan Polysulfate—Agitation—Epirubicin—bone cancer	0.000645	0.00287	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by SCF-KIT—EGFR—bone cancer	0.000641	0.00137	CbGpPWpGaD
Pentosan Polysulfate—Flatulence—Doxorubicin—bone cancer	0.00064	0.00285	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000639	0.00137	CbGpPWpGaD
Pentosan Polysulfate—Arthralgia—Methotrexate—bone cancer	0.000638	0.00284	CcSEcCtD
Pentosan Polysulfate—Myalgia—Methotrexate—bone cancer	0.000638	0.00284	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—BRAF—bone cancer	0.000635	0.00136	CbGpPWpGaD
Pentosan Polysulfate—Malaise—Epirubicin—bone cancer	0.000633	0.00282	CcSEcCtD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.000631	0.00135	CbGpPWpGaD
Pentosan Polysulfate—Discomfort—Methotrexate—bone cancer	0.000631	0.00281	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—bone cancer	0.000628	0.00279	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—ATF1—bone cancer	0.000622	0.00133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—JUN—bone cancer	0.000619	0.00133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—ATF1—bone cancer	0.000618	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—KIT—bone cancer	0.000616	0.00132	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000613	0.00131	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signaling of activated FGFR—EGFR—bone cancer	0.000613	0.00131	CbGpPWpGaD
Pentosan Polysulfate—Infection—Methotrexate—bone cancer	0.000608	0.00271	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—KIT—bone cancer	0.000607	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL3—bone cancer	0.000606	0.0013	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by ERBB4—EGFR—bone cancer	0.000603	0.00129	CbGpPWpGaD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—bone cancer	0.000602	0.00268	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—bone cancer	0.0006	0.00267	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Methotrexate—bone cancer	0.000599	0.00267	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—bone cancer	0.000597	0.00266	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—bone cancer	0.000597	0.00266	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—bone cancer	0.000597	0.00265	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Methotrexate—bone cancer	0.000592	0.00263	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—bone cancer	0.00059	0.00263	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—bone cancer	0.000585	0.00261	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by SCF-KIT—EGFR—bone cancer	0.000584	0.00125	CbGpPWpGaD
Pentosan Polysulfate—Anorexia—Methotrexate—bone cancer	0.000583	0.0026	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KIT—bone cancer	0.000583	0.00125	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000583	0.00125	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP2—bone cancer	0.000582	0.00125	CbGpPWpGaD
Pentosan Polysulfate—Leukopenia—Doxorubicin—bone cancer	0.000581	0.00259	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—BRAF—bone cancer	0.000579	0.00124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Downstream signal transduction—EGFR—bone cancer	0.000576	0.00124	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by FGFR—EGFR—bone cancer	0.000573	0.00123	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling by NGF—EGFR—bone cancer	0.000573	0.00123	CbGpPWpGaD
Pentosan Polysulfate—Oedema—Epirubicin—bone cancer	0.000573	0.00255	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by ERBB2—EGFR—bone cancer	0.00057	0.00122	CbGpPWpGaD
Pentosan Polysulfate—Infection—Epirubicin—bone cancer	0.000569	0.00253	CcSEcCtD
Pentosan Polysulfate—FGF1—DAP12 signaling—EGFR—bone cancer	0.000568	0.00122	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—bone cancer	0.000561	0.00249	CcSEcCtD
Pentosan Polysulfate—FGF1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bone cancer	0.000559	0.0012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling of activated FGFR—EGFR—bone cancer	0.000559	0.0012	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000559	0.0012	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000558	0.00248	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—bone cancer	0.000554	0.00246	CcSEcCtD
Pentosan Polysulfate—Insomnia—Methotrexate—bone cancer	0.000553	0.00246	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—bone cancer	0.000553	0.00246	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—bone cancer	0.000553	0.00246	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB4—EGFR—bone cancer	0.00055	0.00118	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Methotrexate—bone cancer	0.000549	0.00245	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—bone cancer	0.000546	0.00243	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—bone cancer	0.000546	0.00243	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Methotrexate—bone cancer	0.000546	0.00243	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Methotrexate—bone cancer	0.000539	0.0024	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by FGFR in disease—EGFR—bone cancer	0.000534	0.00115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.000534	0.00115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—DAP12 interactions—EGFR—bone cancer	0.000534	0.00115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—MDM2—bone cancer	0.000532	0.00114	CbGpPWpGaD
Pentosan Polysulfate—Decreased appetite—Methotrexate—bone cancer	0.000532	0.00237	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—bone cancer	0.00053	0.00236	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR—EGFR—bone cancer	0.000529	0.00114	CbGpPWpGaD
Pentosan Polysulfate—Infection—Doxorubicin—bone cancer	0.000526	0.00234	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signal transduction—EGFR—bone cancer	0.000525	0.00113	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—EGFR—bone cancer	0.000525	0.00113	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—EGFR—bone cancer	0.000523	0.00112	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—EGFR—bone cancer	0.000522	0.00112	CbGpPWpGaD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000522	0.00232	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—EGFR—bone cancer	0.00052	0.00112	CbGpPWpGaD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—bone cancer	0.000519	0.00231	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—bone cancer	0.000518	0.0023	CcSEcCtD
Pentosan Polysulfate—FGF2—DAP12 signaling—EGFR—bone cancer	0.000518	0.00111	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Epirubicin—bone cancer	0.000514	0.00229	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—bone cancer	0.000512	0.00228	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—bone cancer	0.000511	0.00227	CcSEcCtD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bone cancer	0.00051	0.00109	CbGpPWpGaD
Pentosan Polysulfate—Anorexia—Doxorubicin—bone cancer	0.000505	0.00225	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Methotrexate—bone cancer	0.000504	0.00224	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—bone cancer	0.000504	0.00224	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000503	0.00108	CbGpPWpGaD
Pentosan Polysulfate—Gastrointestinal pain—Methotrexate—bone cancer	0.0005	0.00223	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—bone cancer	0.000498	0.00222	CcSEcCtD
Pentosan Polysulfate—FGF1—B Cell Activation—EGFR—bone cancer	0.000494	0.00106	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—RGS1—bone cancer	0.000491	0.00105	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GRM4—bone cancer	0.000491	0.00105	CbGpPWpGaD
Pentosan Polysulfate—Constipation—Epirubicin—bone cancer	0.00049	0.00218	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—EGFR—bone cancer	0.000487	0.00104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—EGFR—bone cancer	0.000487	0.00104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.000487	0.00104	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Methotrexate—bone cancer	0.000486	0.00216	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—MDM2—bone cancer	0.000485	0.00104	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Methotrexate—bone cancer	0.000484	0.00215	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000483	0.00215	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by EGFR—EGFR—bone cancer	0.000483	0.00104	CbGpPWpGaD
Pentosan Polysulfate—Insomnia—Doxorubicin—bone cancer	0.000479	0.00213	CcSEcCtD
Pentosan Polysulfate—FGF4—Disease—TGFBR2—bone cancer	0.000479	0.00103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—EGFR—bone cancer	0.000478	0.00103	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—MDM2—bone cancer	0.000478	0.00103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—EGFR—bone cancer	0.000476	0.00102	CbGpPWpGaD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—bone cancer	0.000476	0.00212	CcSEcCtD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000473	0.00101	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SMO—bone cancer	0.000473	0.00101	CbGpPWpGaD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—bone cancer	0.000472	0.0021	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—bone cancer	0.000472	0.0021	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—bone cancer	0.000468	0.00208	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—bone cancer	0.000466	0.00208	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—bone cancer	0.000461	0.00205	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—MDM2—bone cancer	0.000459	0.000985	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000458	0.000983	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Epirubicin—bone cancer	0.000455	0.00202	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—bone cancer	0.000453	0.00202	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—bone cancer	0.000453	0.00201	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—ENO2—bone cancer	0.000452	0.000969	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Methotrexate—bone cancer	0.000451	0.00201	CcSEcCtD
Pentosan Polysulfate—FGF2—B Cell Activation—EGFR—bone cancer	0.000451	0.000967	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—RGS1—bone cancer	0.000448	0.00096	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GRM4—bone cancer	0.000448	0.00096	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Extracellular matrix organization—MMP9—bone cancer	0.000438	0.000939	CbGpPWpGaD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—bone cancer	0.000437	0.00194	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—bone cancer	0.000433	0.00193	CcSEcCtD
Pentosan Polysulfate—Pruritus—Methotrexate—bone cancer	0.000433	0.00193	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—GNA11—bone cancer	0.000432	0.000927	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000431	0.000925	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GRM1—bone cancer	0.000426	0.000913	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CDK4—bone cancer	0.000423	0.000907	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MET—bone cancer	0.000423	0.000907	CbGpPWpGaD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—bone cancer	0.000422	0.00188	CcSEcCtD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000422	0.000905	CbGpPWpGaD
Pentosan Polysulfate—Urticaria—Doxorubicin—bone cancer	0.000421	0.00187	CcSEcCtD
Pentosan Polysulfate—FGF1—Disease—DHFR—bone cancer	0.000419	0.000899	CbGpPWpGaD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—bone cancer	0.000419	0.00186	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Methotrexate—bone cancer	0.000419	0.00186	CcSEcCtD
Pentosan Polysulfate—FGF4—Innate Immune System—JUN—bone cancer	0.000416	0.000892	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ENO2—bone cancer	0.000412	0.000884	CbGpPWpGaD
Pentosan Polysulfate—Pruritus—Epirubicin—bone cancer	0.000405	0.0018	CcSEcCtD
Pentosan Polysulfate—Dizziness—Methotrexate—bone cancer	0.000405	0.0018	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—ATF1—bone cancer	0.000402	0.000862	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ATF1—bone cancer	0.000395	0.000846	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL3—bone cancer	0.000392	0.000841	CbGpPWpGaD
Pentosan Polysulfate—Diarrhoea—Epirubicin—bone cancer	0.000392	0.00174	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—bone cancer	0.00039	0.00174	CcSEcCtD
Pentosan Polysulfate—Vomiting—Methotrexate—bone cancer	0.000389	0.00173	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling Pathways—GRM1—bone cancer	0.000388	0.000833	CbGpPWpGaD
Pentosan Polysulfate—Rash—Methotrexate—bone cancer	0.000386	0.00172	CcSEcCtD
Pentosan Polysulfate—FGF1—Innate Immune System—KIT—bone cancer	0.000386	0.000827	CbGpPWpGaD
Pentosan Polysulfate—Dermatitis—Methotrexate—bone cancer	0.000385	0.00172	CcSEcCtD
Pentosan Polysulfate—FGF1—Immune System—IL3—bone cancer	0.000385	0.000825	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000385	0.000825	CbGpPWpGaD
Pentosan Polysulfate—Headache—Methotrexate—bone cancer	0.000383	0.00171	CcSEcCtD
Pentosan Polysulfate—FGF2—Disease—DHFR—bone cancer	0.000382	0.00082	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Epirubicin—bone cancer	0.000379	0.00169	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—bone cancer	0.000375	0.00167	CcSEcCtD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KIT—bone cancer	0.00037	0.000794	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Epirubicin—bone cancer	0.000364	0.00162	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by NGF—EGFR—bone cancer	0.000364	0.00078	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Methotrexate—bone cancer	0.000363	0.00162	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—bone cancer	0.000363	0.00161	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—bone cancer	0.000361	0.00161	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—bone cancer	0.000361	0.00161	CcSEcCtD
Pentosan Polysulfate—FGF2—Immune System—ATF1—bone cancer	0.00036	0.000772	CbGpPWpGaD
Pentosan Polysulfate—Headache—Epirubicin—bone cancer	0.000359	0.0016	CcSEcCtD
Pentosan Polysulfate—FGF4—Immune System—KIT—bone cancer	0.000354	0.000759	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP2—bone cancer	0.000353	0.000757	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KIT—bone cancer	0.000352	0.000754	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL3—bone cancer	0.000351	0.000753	CbGpPWpGaD
Pentosan Polysulfate—Dizziness—Doxorubicin—bone cancer	0.00035	0.00156	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—bone cancer	0.00034	0.00151	CcSEcCtD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KIT—bone cancer	0.000338	0.000724	CbGpPWpGaD
Pentosan Polysulfate—Vomiting—Doxorubicin—bone cancer	0.000337	0.0015	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFBR2—bone cancer	0.000335	0.000719	CbGpPWpGaD
Pentosan Polysulfate—Rash—Doxorubicin—bone cancer	0.000334	0.00149	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—bone cancer	0.000334	0.00149	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—bone cancer	0.000332	0.00148	CcSEcCtD
Pentosan Polysulfate—FGF2—Signaling by NGF—EGFR—bone cancer	0.000332	0.000711	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EGFR—bone cancer	0.000327	0.000701	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KIT—bone cancer	0.000327	0.0007	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF1R—bone cancer	0.000315	0.000676	CbGpPWpGaD
Pentosan Polysulfate—Nausea—Doxorubicin—bone cancer	0.000315	0.0014	CcSEcCtD
Pentosan Polysulfate—FGF4—Adaptive Immune System—EGFR—bone cancer	0.000314	0.000673	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—BRAF—bone cancer	0.000307	0.000658	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFBR2—bone cancer	0.000304	0.000652	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MDM2—bone cancer	0.000304	0.000651	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SMO—bone cancer	0.0003	0.000643	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—MDM2—bone cancer	0.000292	0.000625	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MDM2—bone cancer	0.000279	0.000598	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFBR2—bone cancer	0.000277	0.000594	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MDM2—bone cancer	0.000277	0.000594	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GNA11—bone cancer	0.000274	0.000588	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SMO—bone cancer	0.000274	0.000587	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—MDM2—bone cancer	0.000266	0.00057	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP9—bone cancer	0.000265	0.000569	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—JUN—bone cancer	0.000264	0.000566	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MDM2—bone cancer	0.000257	0.000552	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ATF1—bone cancer	0.000255	0.000547	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GNA11—bone cancer	0.00025	0.000537	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL3—bone cancer	0.000249	0.000534	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—bone cancer	0.000248	0.000532	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—JUN—bone cancer	0.000242	0.000519	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—JUN—bone cancer	0.000241	0.000516	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ATF1—bone cancer	0.000233	0.000499	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KIT—bone cancer	0.000229	0.000491	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL3—bone cancer	0.000227	0.000487	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KIT—bone cancer	0.000225	0.000482	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—BRAF—bone cancer	0.000215	0.000461	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—bone cancer	0.000214	0.000459	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFBR2—bone cancer	0.000213	0.000456	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—bone cancer	0.000208	0.000445	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KIT—bone cancer	0.000207	0.000445	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KIT—bone cancer	0.000205	0.000439	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1R—bone cancer	0.0002	0.000429	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—bone cancer	0.000199	0.000427	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—BRAF—bone cancer	0.000195	0.000418	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFBR2—bone cancer	0.000194	0.000416	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—bone cancer	0.00019	0.000408	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—bone cancer	0.000189	0.000406	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KIT—bone cancer	0.000189	0.000405	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1R—bone cancer	0.000183	0.000391	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—bone cancer	0.000182	0.00039	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MDM2—bone cancer	0.00018	0.000386	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—BRAF—bone cancer	0.000178	0.000381	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MDM2—bone cancer	0.000177	0.000379	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—bone cancer	0.000176	0.000377	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MDM2—bone cancer	0.000163	0.00035	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MDM2—bone cancer	0.000161	0.000346	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—bone cancer	0.000157	0.000338	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JUN—bone cancer	0.000157	0.000336	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JUN—bone cancer	0.000154	0.00033	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—bone cancer	0.000152	0.000327	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MDM2—bone cancer	0.000149	0.000319	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—bone cancer	0.000145	0.000311	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—bone cancer	0.000144	0.000308	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JUN—bone cancer	0.00014	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—BRAF—bone cancer	0.000136	0.000293	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—bone cancer	0.000132	0.000284	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—BRAF—bone cancer	0.000124	0.000267	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—bone cancer	0.000123	0.000264	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—bone cancer	0.000121	0.000259	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MDM2—bone cancer	0.000114	0.000245	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—bone cancer	0.000112	0.000239	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—bone cancer	0.00011	0.000236	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MDM2—bone cancer	0.000104	0.000224	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—bone cancer	0.000103	0.000222	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—bone cancer	0.000102	0.000218	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUN—bone cancer	9.94e-05	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—bone cancer	9.67e-05	0.000207	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUN—bone cancer	9.06e-05	0.000194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—bone cancer	8.82e-05	0.000189	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—bone cancer	7.81e-05	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—bone cancer	7.13e-05	0.000153	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—bone cancer	6.56e-05	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—bone cancer	5.98e-05	0.000128	CbGpPWpGaD
